Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
Eric Ciamporcero, Martina Daga, Stefania Pizzimenti, et al.
Free Radical Biology and Medicine (2017) Vol. 115, pp. 447-457
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D.K. Nguyen, Chunling Yi
Trends in cancer (2019) Vol. 5, Iss. 5, pp. 283-296
Open Access | Times Cited: 313
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BioEssays (2020) Vol. 42, Iss. 5
Open Access | Times Cited: 217
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury
Yuan Liu, Tianfei Lu, Cheng Zhang, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 4, pp. 719-730
Open Access | Times Cited: 206
Nrf2 promotes breast cancer cell migration via up‐regulation of G6PD/HIF‐1α/Notch1 axis
Hongsheng Zhang, Zhongguo Zhang, Guangyuan Du, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 5, pp. 3451-3463
Open Access | Times Cited: 152
Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression
Fabiola Lilí Sarmiento-Salinas, Andrea Perez-Gonzalez, Adilene Acosta-Casique, et al.
Life Sciences (2021) Vol. 284, pp. 119942-119942
Closed Access | Times Cited: 143
Potential Applications of NRF2 Modulators in Cancer Therapy
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 130
YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
Yuan Zhou, Yubo Wang, Wuhua Zhou, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 101
Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells
Leanne Ambrosio, Monica Argenziano, Marie Angèle Cucci, et al.
Antioxidants (2020) Vol. 9, Iss. 10, pp. 993-993
Open Access | Times Cited: 90
Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
Giuseppina Barrera, Marie Angèle Cucci, Margherita Grattarola, et al.
Antioxidants (2021) Vol. 10, Iss. 4, pp. 510-510
Open Access | Times Cited: 63
Microbiota-derived tryptophan metabolites indole-3-lactic acid is associated with intestinal ischemia/reperfusion injury via positive regulation of YAP and Nrf2
Fang-Ling Zhang, Xiaowei Chen, Yifan Wang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Crosstalk between Oxidative Stress and Aging in Neurodegeneration Disorders
Rehab F. Abdelhamid, Seiichi Nagano
Cells (2023) Vol. 12, Iss. 5, pp. 753-753
Open Access | Times Cited: 27
The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway
Jianing Tang, Qian Yang, Chao Mao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1247-1259
Open Access | Times Cited: 26
RETRACTED: Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non‐small cell lung cancer cells via Nrf2 inhibition
Xiangcui Chen, Qipeng Wu, Yueming Chen, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 12, pp. 2079-2094
Open Access | Times Cited: 71
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Yanju Wu, Qianqian Zheng, Yan Li, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 69
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
The mycosporine-like amino acids porphyra-334 and shinorine are antioxidants and direct antagonists of Keap1-Nrf2 binding
Ranko Gaćeša, Karl P. Lawrence, Nikolaos Georgakopoulos, et al.
Biochimie (2018) Vol. 154, pp. 35-44
Open Access | Times Cited: 66
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
Martina Daga, Stefania Pizzimenti, Chiara Dianzani, et al.
Phytomedicine (2018) Vol. 56, pp. 156-164
Open Access | Times Cited: 60
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism
Marie Angèle Cucci, Margherita Grattarola, Chiara Dianzani, et al.
Free Radical Biology and Medicine (2020) Vol. 150, pp. 125-135
Closed Access | Times Cited: 50
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma
Monica Argenziano, Federica Bessone, Chiara Dianzani, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 341-341
Open Access | Times Cited: 29
Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models
Nausicaa Clemente, Monica Argenziano, Casimiro Luca Gigliotti, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 49
Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection
Hadi Ghasemi, Seyed Habibollah Mousavi‐Bahar, Mohammad Hashemnia, et al.
Annals of the New York Academy of Sciences (2020) Vol. 1473, Iss. 1, pp. 48-61
Closed Access | Times Cited: 44
The biology of YAP in programmed cell death
Yifan Cheng, Misha Mao, Yong Lu
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression
Jin Su, Fan Zhang, Xin Li, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 514, Iss. 2, pp. 510-517
Closed Access | Times Cited: 38
A role for YAP/FOXM1/Nrf2 axis in oxidative stress and apoptosis of cataract induced by UVB irradiation
Yingying Hong, Yang Sun, Maierdanjiang Ainiwaer, et al.
The FASEB Journal (2024) Vol. 38, Iss. 14
Closed Access | Times Cited: 4
Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub
Chien‐Chang Kao, Jing-Wen Shih, Huong Thi Luu Kim Huynh, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 5, pp. 1194-1207
Open Access
Page 1 - Next Page

Scroll to top